Proteomic Studies of Nitrated Alpha-Synuclein Microglia Regulation by CD4+CD25+T Cells

被引:61
|
作者
Reynolds, Ashley D. [1 ]
Stone, David K. [1 ]
Mosley, R. Lee [1 ]
Gendelman, Howard E. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
关键词
regulatory T cells; proteomics; microglia; inflammation; Parkinson's disease; alpha-synuclein; PARKINSONS-DISEASE; OXIDATIVE STRESS; T-CELLS; NEURODEGENERATIVE DISORDERS; THERAPEUTIC INTERVENTIONS; MITOCHONDRIAL DYSFUNCTION; MONONUCLEAR PHAGOCYTES; DOPAMINERGIC-NEURONS; CATHEPSIN-B; MOUSE MODEL;
D O I
10.1021/pr9001614
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microglial inflammatory responses affect Parkinson's disease (PD) associated nigrostriatal degeneration. This is triggered, in measure, by misfolded, nitrated alpha-synuclein (N-alpha-syn) contained within Lewy bodies that are released from dying or dead dopaminergic neurons into the extravascular space. N-alpha-syn-stimulated microglial immunity is regulated by CD4+ T cell subset. Indeed, CD4+CD25+ regulatory T cells (Treg) induce neuroprotective immune responses. This is seen in rodent models of stroke, amyotrophic lateral sclerosis, human immunodeficiency virus associated neurocognitive disorders, and PD. To elucidate the mechanism for Treg-mediated microglial neuroregulatory responses, we used a proteomic platform integrating difference gel electrophoresis and tandem mass spectrometry peptide sequencing. These tests served to determine consequences of Treg on the N-alpha-syn stimulated microglia. The data demonstrated that Treg substantially alter the microglial proteome in response to N-alpha-syn. This is seen through Treg abilities to suppress microglial proteins linked to cell metabolism, migration, protein transport and degradation, redox biology, cytoskeletal, and bioenergetic activities. We conclude that Treg modulate the N-a-syn microglial proteome and, in this way, can slow the tempo and course of PD.
引用
收藏
页码:3497 / 3511
页数:15
相关论文
共 50 条
  • [1] Regulation of autoimmunity by CD4+CD25+T cells.
    Thornton, AM
    Shevach, EM
    FASEB JOURNAL, 1999, 13 (05): : A1127 - A1127
  • [2] CD4+CD25+T regulatory cells in autoimmune diseases
    Valencia, X
    He, LS
    Illei, G
    Lipsky, PE
    FASEB JOURNAL, 2004, 18 (05): : A832 - A832
  • [3] Alpha-synuclein induces MHCII dependent CD4 T cell proliferation and activation of microglia
    Harms, Ashley S.
    Cao, Shuwen
    Rowse, Amber L.
    Cron, Randy Q.
    Raman, Chander
    Standaert, David G.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 98 - 99
  • [4] Corticosteroids increase the percentage of CD4+CD25+T regulatory cells
    Braitch, M
    Harikrishhnan, S
    Robins, A
    Constantinescu, C
    IMMUNOLOGY, 2005, 116 : 87 - 87
  • [5] An essential role for Scurfin in CD4+CD25+T regulatory cells
    Khattri, Roli
    Cox, Tom
    Yasayko, Sue-Ann
    Ramsdell, Fred
    JOURNAL OF IMMUNOLOGY, 2017, 198 (03): : 993 - 998
  • [6] Corticosteroids increase the percentage of CD4+CD25+T regulatory cells
    Braitch, M
    Harikrishnan, S
    Robins, RA
    Tench, CR
    Constantinescu, CS
    MULTIPLE SCLEROSIS, 2005, 11 : S166 - S166
  • [7] CD4+CD25+T regulatory cells in systemic lupus erythematosus
    Valencia, X
    He, LS
    Illei, G
    Lipsky, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3404 - 3404
  • [8] The role of CD4+CD25+t regulatory cells in autoimmune diseases
    Toubi, E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (03) : 338 - 344
  • [9] The role of CD4+CD25+T cells in laboratory animal allergy
    Jeal, H.
    Jones, M.
    Taylor, A. Newman
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (09): : 1202 - 1202
  • [10] CD4+CD25+T regulatory cells in autoimmune diseases.
    Valencia, X
    Olson, D
    He, LS
    Illei, G
    Lipsky, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S194 - S194